ID   CAF1A_HUMAN             Reviewed;         956 AA.
AC   Q13111; Q6NXG5; Q7Z7K3; Q9UJY8;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2018, sequence version 3.
DT   28-JAN-2026, entry version 215.
DE   RecName: Full=Chromatin assembly factor 1 subunit A {ECO:0000305};
DE            Short=CAF-1 subunit A;
DE   AltName: Full=Chromatin assembly factor I p150 subunit;
DE            Short=CAF-I 150 kDa subunit;
DE            Short=CAF-I p150;
DE            Short=hp150;
GN   Name=CHAF1A {ECO:0000312|HGNC:HGNC:1910}; Synonyms=CAF, CAF1P150;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORMS 1; 2 AND
RP   3), AND VARIANT VAL-923.
RX   PubMed=11250073; DOI=10.1016/s0378-1119(01)00335-3;
RA   Dong H., Lin W., Zhang C.-K., Xiong H., Fu G., Jin W.-R., Chen R., Chen Z.,
RA   Qi Z.-T., Huang G.M.;
RT   "Genomic sequence and expression analyses of human chromatin assembly
RT   factor 1 p150 gene.";
RL   Gene 264:187-196(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-956 (ISOFORM 1), AND VARIANT VAL-923.
RC   TISSUE=Cervix adenocarcinoma;
RX   PubMed=7600578; DOI=10.1016/s0092-8674(05)80015-7;
RA   Kaufman P.D., Kobayashi R., Kessler N., Stillman B.;
RT   "The p150 and p60 subunits of chromatin assembly factor I: a molecular link
RT   between newly synthesized histones and DNA replication.";
RL   Cell 81:1105-1114(1995).
RN   [5]
RP   INTERACTION WITH PCNA, AND SUBCELLULAR LOCATION.
RX   PubMed=10052459; DOI=10.1016/s0092-8674(00)80661-3;
RA   Shibahara K., Stillman B.;
RT   "Replication-dependent marking of DNA by PCNA facilitates CAF-1-coupled
RT   inheritance of chromatin.";
RL   Cell 96:575-585(1999).
RN   [6]
RP   INTERACTION WITH PCNA.
RX   PubMed=10648606; DOI=10.1128/mcb.20.4.1206-1218.2000;
RA   Moggs J.G., Grandi P., Quivy J.P., Jonsson Z.O., Hubscher U., Becker P.B.,
RA   Almouzni G.;
RT   "A CAF-1-PCNA-mediated chromatin assembly pathway triggered by sensing DNA
RT   damage.";
RL   Mol. Cell. Biol. 20:1206-1218(2000).
RN   [7]
RP   REVIEW.
RX   PubMed=10893180; DOI=10.1242/jcs.113.15.2647;
RA   Ridgway P., Almouzni G.;
RT   "CAF-1 and the inheritance of chromatin states: at the crossroads of DNA
RT   replication and repair.";
RL   J. Cell Sci. 113:2647-2658(2000).
RN   [8]
RP   HOMODIMERIZATION.
RX   PubMed=11296234; DOI=10.1093/emboj/20.8.2015;
RA   Quivy J.-P., Grandi P., Almouzni G.;
RT   "Dimerization of the largest subunit of chromatin assembly factor 1:
RT   importance in vitro and during Xenopus early development.";
RL   EMBO J. 20:2015-2027(2001).
RN   [9]
RP   INTERACTION WITH MBD1.
RX   PubMed=12697822; DOI=10.1128/mcb.23.9.3226-3236.2003;
RA   Reese B.E., Bachman K.E., Baylin S.B., Rountree M.R.;
RT   "The methyl-CpG binding protein MBD1 interacts with the p150 subunit of
RT   chromatin assembly factor 1.";
RL   Mol. Cell. Biol. 23:3226-3236(2003).
RN   [10]
RP   FUNCTION, INTERACTION WITH MBD1 AND SETDB1, AND RETRACTED PAPER.
RX   PubMed=15327775; DOI=10.1016/j.molcel.2004.06.043;
RA   Sarraf S.A., Stancheva I.;
RT   "Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9
RT   by SETDB1 to DNA replication and chromatin assembly.";
RL   Mol. Cell 15:595-605(2004).
RN   [11]
RP   RETRACTION NOTICE OF PUBMED:15327775.
RX   PubMed=30849389; DOI=10.1016/j.molcel.2019.02.023;
RA   Sarraf S.A., Stancheva I.;
RT   "Retraction Notice to: Methyl-CpG Binding Protein MBD1 Couples Histone H3
RT   Methylation at Lysine 9 by SETDB1 to DNA Replication and Chromatin
RT   Assembly.";
RL   Mol. Cell 73:1084-1084(2019).
RN   [12]
RP   INTERACTION WITH CBX5.
RX   PubMed=15882967; DOI=10.1016/j.bbrc.2005.04.016;
RA   Lechner M.S., Schultz D.C., Negorev D., Maul G.G., Rauscher F.J. III;
RT   "The mammalian heterochromatin protein 1 binds diverse nuclear proteins
RT   through a common motif that targets the chromoshadow domain.";
RL   Biochem. Biophys. Res. Commun. 331:929-937(2005).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224; THR-722; SER-772;
RP   SER-775; SER-873 AND SER-951, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   INTERACTION WITH CBX5, AND MUTAGENESIS OF VAL-240 AND LEU-242.
RX   PubMed=20562864; DOI=10.1038/ncb2075;
RA   Nozawa R.S., Nagao K., Masuda H.T., Iwasaki O., Hirota T., Nozaki N.,
RA   Kimura H., Obuse C.;
RT   "Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms
RT   through Aurora B activation.";
RL   Nat. Cell Biol. 12:719-727(2010).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-123; SER-138; SER-141;
RP   SER-143; SER-224; THR-722; SER-772; THR-865; SER-873 AND SER-951, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-141; SER-143;
RP   SER-206; THR-722; SER-772; SER-775 AND SER-951, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141; SER-206; SER-310;
RP   SER-772; SER-803; SER-868 AND SER-873, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-182, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-182, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [24]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-182, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [25]
RP   INTERACTION WITH HISTONES H3.1; H3.2 AND H3.1T.
RX   PubMed=33857403; DOI=10.1016/j.molcel.2021.03.041;
RA   Hammond C.M., Bao H., Hendriks I.A., Carraro M., Garcia-Nieto A., Liu Y.,
RA   Reveron-Gomez N., Spanos C., Chen L., Rappsilber J., Nielsen M.L.,
RA   Patel D.J., Huang H., Groth A.;
RT   "DNAJC9 integrates heat shock molecular chaperones into the histone
RT   chaperone network.";
RL   Mol. Cell 0:0-0(2021).
CC   -!- FUNCTION: Acts as a component of the histone chaperone complex
CC       chromatin assembly factor 1 (CAF-1), which assembles histone octamers
CC       onto DNA during replication and repair. CAF-1 performs the first step
CC       of the nucleosome assembly process, bringing newly synthesized histones
CC       H3 and H4 to replicating DNA; histones H2A/H2B can bind to this
CC       chromatin precursor subsequent to DNA replication to complete the
CC       histone octamer. It may play a role in heterochromatin maintenance in
CC       proliferating cells by bringing newly synthesized cbx proteins to
CC       heterochromatic DNA replication foci. {ECO:0000250|UniProtKB:Q5R1T0}.
CC   -!- SUBUNIT: Homodimer. Part of the CAF-1 complex that contains RBBP4,
CC       CHAF1B and CHAF1A. CHAF1A binds directly to CHAF1B. Only minor amounts
CC       of RBBP4 are complexed with CHAF1A and CHAF1B in G1 phase. Interacts
CC       with PCNA; the interaction is direct (PubMed:10052459,
CC       PubMed:10648606). Interacts (via the PxVxL motif) with CBX5; the
CC       interaction is direct (PubMed:15882967, PubMed:20562864). Interacts
CC       with MBD1 (PubMed:12697822). Interacts with histones H3.1, H3.2 and
CC       H3.1t (PubMed:33857403). {ECO:0000269|PubMed:10052459,
CC       ECO:0000269|PubMed:10648606, ECO:0000269|PubMed:12697822,
CC       ECO:0000269|PubMed:15882967, ECO:0000269|PubMed:20562864,
CC       ECO:0000269|PubMed:33857403}.
CC   -!- INTERACTION:
CC       Q13111; Q9NVP2: ASF1B; NbExp=7; IntAct=EBI-1020839, EBI-1055650;
CC       Q13111; P45973: CBX5; NbExp=8; IntAct=EBI-1020839, EBI-78219;
CC       Q13111; Q13111: CHAF1A; NbExp=3; IntAct=EBI-1020839, EBI-1020839;
CC       Q13111; Q99684: GFI1; NbExp=4; IntAct=EBI-1020839, EBI-949368;
CC       Q13111; P84243: H3-3B; NbExp=3; IntAct=EBI-1020839, EBI-120658;
CC       Q13111; Q71DI3: H3C15; NbExp=2; IntAct=EBI-1020839, EBI-750650;
CC       Q13111; Q9UIS9: MBD1; NbExp=3; IntAct=EBI-1020839, EBI-867196;
CC       Q13111; A8MW99: MEI4; NbExp=3; IntAct=EBI-1020839, EBI-19944212;
CC       Q13111; P16333: NCK1; NbExp=2; IntAct=EBI-1020839, EBI-389883;
CC       Q13111; A8MTQ0: NOTO; NbExp=3; IntAct=EBI-1020839, EBI-17490746;
CC       Q13111; P26367: PAX6; NbExp=3; IntAct=EBI-1020839, EBI-747278;
CC       Q13111; P12004: PCNA; NbExp=4; IntAct=EBI-1020839, EBI-358311;
CC       Q13111; P27986: PIK3R1; NbExp=2; IntAct=EBI-1020839, EBI-79464;
CC       Q13111; P78424: POU6F2; NbExp=3; IntAct=EBI-1020839, EBI-12029004;
CC       Q13111; Q04864: REL; NbExp=3; IntAct=EBI-1020839, EBI-307352;
CC       Q13111; Q04864-2: REL; NbExp=3; IntAct=EBI-1020839, EBI-10829018;
CC       Q13111; Q9UHV2: SERTAD1; NbExp=3; IntAct=EBI-1020839, EBI-748601;
CC       Q13111; P51692: STAT5B; NbExp=3; IntAct=EBI-1020839, EBI-1186119;
CC       Q13111; P15884: TCF4; NbExp=3; IntAct=EBI-1020839, EBI-533224;
CC       Q13111; P15884-3: TCF4; NbExp=3; IntAct=EBI-1020839, EBI-13636688;
CC       Q13111; Q96RU7: TRIB3; NbExp=5; IntAct=EBI-1020839, EBI-492476;
CC       Q13111; P62258: YWHAE; NbExp=3; IntAct=EBI-1020839, EBI-356498;
CC       Q13111; Q6ZNG0: ZNF620; NbExp=3; IntAct=EBI-1020839, EBI-4395669;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10052459}. Note=DNA
CC       replication foci.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Experimental confirmation may be lacking for some isoforms.;
CC       Name=1;
CC         IsoId=Q13111-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13111-2; Sequence=VSP_004149, VSP_004150;
CC       Name=3;
CC         IsoId=Q13111-3; Sequence=VSP_004151;
CC   -!- DEVELOPMENTAL STAGE: Active complex is found in G1, S and G2 phases.
CC   -!- DOMAIN: Contains one Pro-Xaa-Val-Xaa-Leu (PxVxL) motif, which is
CC       required for interaction with chromoshadow domains. This motif requires
CC       additional residues -7, -6, +4 and +5 of the central Val which contact
CC       the chromoshadow domain.
CC   -!- SIMILARITY: Belongs to the CHAF1A family. {ECO:0000305}.
CC   -!- CAUTION: Was reported to form, during DNA replication, a S phase-
CC       specific complex that would facilitate methylation of H3 'Lys-9' during
CC       replication-coupled chromatin assembly and vould be at least composed
CC       of the CAF-1 subunit CHAF1A, MBD1 and SETDB1 (PubMed:15327775).
CC       However, this paper has been retracted because some data, results and
CC       conclusions are not reliable (PubMed:30849389).
CC       {ECO:0000269|PubMed:15327775, ECO:0000269|PubMed:30849389}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA76736.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAF04291.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH52620.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH52620.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence starting in position 426.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF190465; AAF04291.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AC011498; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF459577; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC052620; AAH52620.1; ALT_SEQ; mRNA.
DR   EMBL; BC067093; AAH67093.1; -; mRNA.
DR   EMBL; U20979; AAA76736.1; ALT_INIT; mRNA.
DR   CCDS; CCDS32875.1; -. [Q13111-1]
DR   PIR; A56731; A56731.
DR   RefSeq; NP_005474.2; NM_005483.3. [Q13111-1]
DR   PDB; 7Y5K; X-ray; 3.48 A; A=442-714.
DR   PDB; 7Y5L; X-ray; 3.42 A; A/D=442-714.
DR   PDB; 7Y5O; X-ray; 3.57 A; A/D=442-714.
DR   PDB; 7Y5U; EM; 3.80 A; A=442-853.
DR   PDB; 7Y5V; EM; 6.10 A; A/F=442-853.
DR   PDB; 7Y60; EM; 3.80 A; K=442-853.
DR   PDB; 7Y61; EM; 5.60 A; K/M=442-853.
DR   PDB; 8IQF; EM; 4.60 A; A/F=1-956.
DR   PDB; 8IQG; EM; 3.50 A; A=1-956.
DR   PDB; 8J6S; EM; 3.80 A; K=1-956.
DR   PDB; 8J6T; EM; 6.60 A; K/M=1-956.
DR   PDBsum; 7Y5K; -.
DR   PDBsum; 7Y5L; -.
DR   PDBsum; 7Y5O; -.
DR   PDBsum; 7Y5U; -.
DR   PDBsum; 7Y5V; -.
DR   PDBsum; 7Y60; -.
DR   PDBsum; 7Y61; -.
DR   PDBsum; 8IQF; -.
DR   PDBsum; 8IQG; -.
DR   PDBsum; 8J6S; -.
DR   PDBsum; 8J6T; -.
DR   AlphaFoldDB; Q13111; -.
DR   EMDB; EMD-33625; -.
DR   EMDB; EMD-33626; -.
DR   EMDB; EMD-33630; -.
DR   EMDB; EMD-33631; -.
DR   EMDB; EMD-35660; -.
DR   EMDB; EMD-35661; -.
DR   EMDB; EMD-36013; -.
DR   EMDB; EMD-36014; -.
DR   SASBDB; Q13111; -.
DR   SMR; Q13111; -.
DR   BioGRID; 115349; 210.
DR   ComplexPortal; CPX-569; Chromatin assembly factor 1 complex.
DR   CORUM; Q13111; -.
DR   DIP; DIP-31135N; -.
DR   ELM; Q13111; -.
DR   FunCoup; Q13111; 1408.
DR   IntAct; Q13111; 84.
DR   MINT; Q13111; -.
DR   STRING; 9606.ENSP00000301280; -.
DR   GlyGen; Q13111; 2 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q13111; -.
DR   PhosphoSitePlus; Q13111; -.
DR   SwissPalm; Q13111; -.
DR   BioMuta; CHAF1A; -.
DR   DMDM; 229462842; -.
DR   jPOST; Q13111; -.
DR   MassIVE; Q13111; -.
DR   PaxDb; 9606-ENSP00000301280; -.
DR   PeptideAtlas; Q13111; -.
DR   ProteomicsDB; 59160; -. [Q13111-1]
DR   ProteomicsDB; 59161; -. [Q13111-2]
DR   ProteomicsDB; 59162; -. [Q13111-3]
DR   Pumba; Q13111; -.
DR   Antibodypedia; 4198; 243 antibodies from 34 providers.
DR   DNASU; 10036; -.
DR   Ensembl; ENST00000301280.10; ENSP00000301280.4; ENSG00000167670.17. [Q13111-1]
DR   GeneID; 10036; -.
DR   KEGG; hsa:10036; -.
DR   MANE-Select; ENST00000301280.10; ENSP00000301280.4; NM_005483.3; NP_005474.2.
DR   UCSC; uc002mal.4; human. [Q13111-1]
DR   AGR; HGNC:1910; -.
DR   ClinPGx; PA26446; -.
DR   CTD; 10036; -.
DR   DisGeNET; 10036; -.
DR   GeneCards; CHAF1A; -.
DR   HGNC; HGNC:1910; CHAF1A.
DR   HPA; ENSG00000167670; Tissue enhanced (bone).
DR   MIM; 601246; gene.
DR   OpenTargets; ENSG00000167670; -.
DR   VEuPathDB; HostDB:ENSG00000167670; -.
DR   eggNOG; KOG4364; Eukaryota.
DR   GeneTree; ENSGT00440000034888; -.
DR   HOGENOM; CLU_014846_0_0_1; -.
DR   InParanoid; Q13111; -.
DR   OMA; DPWAQDK; -.
DR   OrthoDB; 79480at2759; -.
DR   PAN-GO; Q13111; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; Q13111; -.
DR   PathwayCommons; Q13111; -.
DR   SignaLink; Q13111; -.
DR   SIGNOR; Q13111; -.
DR   Agora; ENSG00000167670; -.
DR   BioGRID-ORCS; 10036; 769 hits in 1168 CRISPR screens.
DR   ChiTaRS; CHAF1A; human.
DR   GeneWiki; CHAF1A; -.
DR   GenomeRNAi; 10036; -.
DR   Pharos; Q13111; Tbio.
DR   PRO; PR:Q13111; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q13111; protein.
DR   Bgee; ENSG00000167670; Expressed in secondary oocyte and 202 other cell types or tissues.
DR   ExpressionAtlas; Q13111; baseline and differential.
DR   GO; GO:0033186; C:CAF-1 complex; IDA:UniProtKB.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; TAS:ProtInc.
DR   GO; GO:0070087; F:chromo shadow domain binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:ProtInc.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0006335; P:DNA replication-dependent chromatin assembly; IDA:GO_Central.
DR   GO; GO:0006334; P:nucleosome assembly; IDA:GO_Central.
DR   InterPro; IPR021644; CAF-1_p150_acidic.
DR   InterPro; IPR029105; CAF1-p150_C2.
DR   InterPro; IPR029091; CAF1_p150_N.
DR   InterPro; IPR022043; CAF1A_DD.
DR   PANTHER; PTHR15272:SF0; CHROMATIN ASSEMBLY FACTOR 1 SUBUNIT A; 1.
DR   PANTHER; PTHR15272; CHROMATIN ASSEMBLY FACTOR 1 SUBUNIT A CAF-1 SUBUNIT A; 1.
DR   Pfam; PF15539; CAF1-p150_C2; 1.
DR   Pfam; PF15557; CAF1-p150_N; 1.
DR   Pfam; PF11600; CAF1A_acidic; 1.
DR   Pfam; PF12253; CAF1A_dimeriz; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Chaperone;
KW   Chromatin regulator; DNA damage; DNA repair; DNA replication;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN           1..956
FT                   /note="Chromatin assembly factor 1 subunit A"
FT                   /id="PRO_0000089276"
FT   REGION          1..314
FT                   /note="Binds to CBX1 chromo shadow domain"
FT   REGION          1..49
FT                   /note="Binds to PCNA"
FT   REGION          45..65
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          122..155
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          188..222
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          250..432
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          599..639
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          642..678
FT                   /note="Necessary for homodimerization and competence for
FT                   chromatin assembly"
FT   REGION          660..956
FT                   /note="Binds to p60"
FT   REGION          765..790
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          844..873
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          933..956
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           233..246
FT                   /note="PxVxL motif"
FT   COMPBIAS        56..65
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        282..296
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        307..317
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        329..432
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        599..610
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        618..633
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        767..786
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        855..866
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         65
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         123
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         138
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         141
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         206
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         224
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         722
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         772
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         775
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         803
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         865
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         868
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         873
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         951
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   CROSSLNK        182
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        182
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         710..749
FT                   /note="CFLETLPAQEEQTPKASKRERRDEQILAQLLPLLHGNVNG -> HWVHPESR
FT                   GDVCRTLRVSSPQSRYLNRLNSCVKSTLSCFT (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_004149"
FT   VAR_SEQ         750..956
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_004150"
FT   VAR_SEQ         772..944
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_004151"
FT   VARIANT         167
FT                   /note="D -> V (in dbSNP:rs35651457)"
FT                   /id="VAR_055329"
FT   VARIANT         239
FT                   /note="M -> V (in dbSNP:rs2230635)"
FT                   /id="VAR_055330"
FT   VARIANT         850
FT                   /note="K -> R (in dbSNP:rs8100525)"
FT                   /id="VAR_055331"
FT   VARIANT         923
FT                   /note="A -> V (in dbSNP:rs9352)"
FT                   /evidence="ECO:0000269|PubMed:11250073,
FT                   ECO:0000269|PubMed:7600578"
FT                   /id="VAR_055332"
FT   VARIANT         950
FT                   /note="A -> S (in dbSNP:rs243383)"
FT                   /id="VAR_055333"
FT   MUTAGEN         240
FT                   /note="V->E: Abolishes interaction with CBX5; when
FT                   associated with E-242."
FT                   /evidence="ECO:0000269|PubMed:20562864"
FT   MUTAGEN         242
FT                   /note="L->E: Abolishes interaction with CBX5; when
FT                   associated with E-240."
FT                   /evidence="ECO:0000269|PubMed:20562864"
FT   CONFLICT        775
FT                   /note="S -> T (in Ref. 4; AAA76736)"
FT                   /evidence="ECO:0000305"
FT   STRAND          477..479
FT                   /evidence="ECO:0007829|PDB:7Y5L"
FT   HELIX           491..501
FT                   /evidence="ECO:0007829|PDB:7Y5L"
FT   HELIX           508..513
FT                   /evidence="ECO:0007829|PDB:7Y5L"
FT   STRAND          538..543
FT                   /evidence="ECO:0007829|PDB:7Y5L"
FT   HELIX           551..554
FT                   /evidence="ECO:0007829|PDB:7Y5L"
FT   STRAND          558..561
FT                   /evidence="ECO:0007829|PDB:7Y5L"
FT   STRAND          570..572
FT                   /evidence="ECO:0007829|PDB:7Y5L"
FT   TURN            591..593
FT                   /evidence="ECO:0007829|PDB:7Y5L"
FT   HELIX           600..603
FT                   /evidence="ECO:0007829|PDB:7Y5K"
FT   STRAND          614..620
FT                   /evidence="ECO:0007829|PDB:8IQG"
FT   STRAND          630..632
FT                   /evidence="ECO:0007829|PDB:8IQG"
FT   HELIX           636..646
FT                   /evidence="ECO:0007829|PDB:8IQG"
FT   STRAND          659..663
FT                   /evidence="ECO:0007829|PDB:7Y5L"
FT   HELIX           665..674
FT                   /evidence="ECO:0007829|PDB:7Y5L"
FT   STRAND          684..686
FT                   /evidence="ECO:0007829|PDB:7Y5L"
FT   STRAND          694..696
FT                   /evidence="ECO:0007829|PDB:7Y5L"
FT   HELIX           698..705
FT                   /evidence="ECO:0007829|PDB:7Y5L"
SQ   SEQUENCE   956 AA;  106910 MW;  90617F8FE8DB7FD0 CRC64;
     MLEELECGAP GARGAATAMD CKDRPAFPVK KLIQARLPFK RLNLVPKGKA DDMSDDQGTS
     VQSKSPDLEA SLDTLENNCH VGSDIDFRPK LVNGKGPLDN FLRNRIETSI GQSTVIIDLT
     EDSNEQPDSL VDHNKLNSEA SPSREAINGQ REDTGDQQGL LKAIQNDKLA FPGETLSDIP
     CKTEEEGVGC GGAGRRGDSQ ECSPRSCPEL TSGPRMCPRK EQDSWSEAGG ILFKGKVPMV
     VLQDILAVRP PQIKSLPATP QGKNMTPESE VLESFPEEDS VLSHSSLSSP SSTSSPEGPP
     APPKQHSSTS PFPTSTPLRR ITKKFVKGST EKNKLRLQRD QERLGKQLKL RAEREEKEKL
     KEEAKRAKEE AKKKKEEEKE LKEKERREKR EKDEKEKAEK QRLKEERRKE RQEALEAKLE
     EKRKKEEEKR LREEEKRIKA EKAEITRFFQ KPKTPQAPKT LAGSCGKFAP FEIKEHMVLA
     PRRRTAFHPD LCSQLDQLLQ QQSGEFSFLK DLKGRQPLRS GPTHVSTRNA DIFNSDVVIV
     ERGKGDGVPE RRKFGRMKLL QFCENHRPAY WGTWNKKTAL IRARDPWAQD TKLLDYEVDS
     DEEWEEEEPG ESLSHSEGDD DDDMGEDEDE DDGFFVPHGY LSEDEGVTEE CADPENHKVR
     QKLKAKEWDE FLAKGKRFRV LQPVKIGCVW AADRDCAGDD LKVLQQFAAC FLETLPAQEE
     QTPKASKRER RDEQILAQLL PLLHGNVNGS KVIIREFQEH CRRGLLSNHT GSPRSPSTTY
     LHTPTPSEDA AIPSKSRLKR LISENSVYEK RPDFRMCWYV HPQVLQSFQQ EHLPVPCQWS
     YVTSVPSAPK EDSGSVPSTG PSQGTPISLK RKSAGSMCIT QFMKKRRHDG QIGAEDMDGF
     QADTEEEEEE EGDCMIVDVP DAAEVQAPCG AASGAGGGVG VDTGKATLTA SPLGAS
//
